• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CSCO breast cancer guideline: precise, economical and oriental.

作者信息

Li Qian, Liu Jieqiong, Jiang Zefei, Liu Qiang

机构信息

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.

Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.

出版信息

Sci China Life Sci. 2020 Sep;63(9):1410-1412. doi: 10.1007/s11427-020-1701-5. Epub 2020 Jun 12.

DOI:10.1007/s11427-020-1701-5
PMID:32548693
Abstract
摘要

相似文献

1
CSCO breast cancer guideline: precise, economical and oriental.中国临床肿瘤学会（CSCO）乳腺癌诊疗指南：精准、经济、东方特色。
Sci China Life Sci. 2020 Sep;63(9):1410-1412. doi: 10.1007/s11427-020-1701-5. Epub 2020 Jun 12.
2
Breast cancer and genomic testing.乳腺癌与基因检测
Br J Surg. 2017 Jun;104(7):799-801. doi: 10.1002/bjs.10513. Epub 2017 Mar 16.
3
Steps forward for cancer precision medicine.癌症精准医学的新进展。
Nat Rev Drug Discov. 2018 Jan;17(1):1-2. doi: 10.1038/nrd.2017.218. Epub 2017 Nov 24.
4
Precision Medicine in Breast Cancer.乳腺癌中的精准医学
Radiol Technol. 2017 Mar;88(4):401M-421M.
5
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification.2022年中国临床肿瘤学会乳腺癌（CSCO BC）指南：分层与分类
Cancer Biol Med. 2022 Jun 29;19(6):769-73. doi: 10.20892/j.issn.2095-3941.2022.0277.
6
Editorial: Management Based on Risk: Individualizing the Care of the Breast Cancer Patient.社论：基于风险的管理：乳腺癌患者的个体化护理
Ann Surg Oncol. 2016 Oct;23(10):3083-7. doi: 10.1245/s10434-016-5371-4. Epub 2016 Jul 12.
7
Clinical Risk During the Evaluation of Genomic Risk for Hormone-Sensitive Breast Cancer: Ignoring Valuable Data.激素敏感性乳腺癌基因组风险评估中的临床风险：忽视有价值的数据。
J Natl Compr Canc Netw. 2019 Dec;17(12):1456-1458. doi: 10.6004/jnccn.2019.7363.
8
[Clinical practice guideline for breast cancer].[乳腺癌临床实践指南]
Nihon Rinsho. 2007 Jun 28;65 Suppl 6:175-81.
9
Contribution of biomarkers to personalized medicine.生物标志物在个性化医疗中的作用。
Breast Cancer Res. 2010 Dec 20;12 Suppl 4(Suppl 4):S3. doi: 10.1186/bcr2732.
10
Treatment strategy for metastatic breast cancer according to intrinsic subtype.根据内在亚型制定的转移性乳腺癌治疗策略。
Int J Clin Oncol. 2010 Aug;15(4):333-4. doi: 10.1007/s10147-010-0102-5. Epub 2010 Jul 15.

引用本文的文献

1
Enhanced HER-2 prediction in breast cancer through synergistic integration of deep learning, ultrasound radiomics, and clinical data.通过深度学习、超声影像组学和临床数据的协同整合增强乳腺癌中HER-2的预测
Sci Rep. 2025 Jul 24;15(1):26992. doi: 10.1038/s41598-025-12825-7.
2
Intra- and peritumoral radiomics nomogram based on DCE-MRI for the early prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer.基于动态对比增强磁共振成像（DCE-MRI）的瘤内及瘤周影像组学列线图用于早期预测乳腺癌新辅助化疗的病理完全缓解
Front Oncol. 2025 Jun 4;15:1561599. doi: 10.3389/fonc.2025.1561599. eCollection 2025.
3
The Safety and Efficacy of Anticancer Therapy in Breast Cancer Patients with Liver Cirrhosis.
抗癌疗法对肝硬化乳腺癌患者的安全性与有效性
Cancer Manag Res. 2025 Mar 19;17:639-650. doi: 10.2147/CMAR.S503109. eCollection 2025.
4
Adjuvant treatment strategy evolution and risk stratification for hormone receptor-positive, human epidermal growth factor receptor-2 negative early breast cancer in China.中国激素受体阳性、人表皮生长因子受体-2 阴性早期乳腺癌的辅助治疗策略演变与风险分层。
Oncologist. 2024 Sep 6;29(9):e1104-e1112. doi: 10.1093/oncolo/oyae095.
5
Locoregional recurrence and survival of breast-conserving surgery compared to mastectomy following neoadjuvant chemotherapy in operable breast cancer.可手术乳腺癌新辅助化疗后保乳手术与乳房切除术的局部区域复发及生存情况比较
Front Oncol. 2024 Mar 28;14:1308343. doi: 10.3389/fonc.2024.1308343. eCollection 2024.
6
HER2-targeted therapies in cancer: a systematic review.癌症中的HER2靶向治疗：一项系统评价。
Biomark Res. 2024 Feb 2;12(1):16. doi: 10.1186/s40364-024-00565-1.
7
Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer.细胞质 YAP1 介导的 ESCRT-III 组装促进自噬性细胞死亡，并在乳腺癌中被 NEDD4L 泛素化。
Cancer Commun (Lond). 2023 May;43(5):582-612. doi: 10.1002/cac2.12417. Epub 2023 Apr 2.
8
Analysis of the clinicopathological characteristics and prognosis of triple-positive breast cancer and HER2-positive breast cancer-A retrospective study.三阳性乳腺癌与HER2阳性乳腺癌的临床病理特征及预后分析——一项回顾性研究
Front Oncol. 2023 Jan 12;12:999894. doi: 10.3389/fonc.2022.999894. eCollection 2022.
9
Expression of yes-associated protein, β-catenin and smoothened, and their clinical significance in invasive breast cancer.Yes相关蛋白、β-连环蛋白和平滑肌细胞蛋白在浸润性乳腺癌中的表达及其临床意义
Exp Ther Med. 2022 Jun;23(6):429. doi: 10.3892/etm.2022.11356. Epub 2022 May 6.
10
Prognostic factors of primary neuroendocrine breast cancer: A population-based study.原发性神经内分泌乳腺癌的预后因素：一项基于人群的研究。
Cancer Med. 2022 Jul;11(13):2533-2540. doi: 10.1002/cam4.4557. Epub 2022 May 2.